CI_with has_Ingredient has_MoA has_PE may_treat drug associated with AE in adult used to treat disease Monoamine Oxidase Inhibitors [MoA] Alzheimer Disease [Disease/Finding] Attention Deficit Disorder with Hyperactivity [Disease/Finding] Depressive Disorder [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Parkinson Disease [Disease/Finding] Schizophrenia [Disease/Finding] Selegiline [Chemical/Ingredient] Increased Central Nervous System Dopamine Activity [PE] S [Preparations] SELEGILINE http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021479s003s004lbl.pdf 4019929 9639 N0000148014 Ingredient <VANDF_Record>50.6^2121^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>2121</VA_IEN> C0036579 C19766 SELEGILINE 2K1V7GP655 Selegiline Active <VANDF_Record>50.416^2554^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>2554</VA_IEN> Parkinson's disease dyskinesia AE rhinitis AE pain AE headache AE dizziness AE back pain AE dyspepsia AE nausea AE stomatitis AE insomnia AE